End Stage Renal Disease
7 competing products in clinical development for End Stage Renal Disease.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 22
Approved3
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Astagraf XL + Prograf + Mycophenolate mofetil | Astellas Pharma | Approved | Completed | 43 |
| Tacrolimus Extended-Release Oral Capsule | Astellas Pharma | Approved | Completed | 43 |
| donepezil HCl + donepezil HCl | Eisai | Approved | Completed | 43 |
| Drotrecogin alfa activated (Xigris) | Eli Lilly | Phase 2 | Completed | 35 |
| Roxadustat + Epoetin Alfa | Astellas Pharma | Phase 2 | Completed | 35 |
| Conversion to Advagraf + conversion of non-immunosuppressant drugs to once daily + Conversion to once daily MPA | Astellas Pharma | Pre-clinical | Active | 30 |
| Plazomicin Injection | Cipla | Phase 1 | Completed | 29 |